Cargando…

Application Progress of High-Throughput Sequencing in Ocular Diseases

Ocular diseases affect multiple eye parts and can be caused by pathogenic infections, complications of systemic diseases, genetics, environment, and old age. Understanding the etiology and pathogenesis of eye diseases and improving their diagnosis and treatment are critical for preventing any advers...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xuejun, Zhang, Ningzhi, Cao, Wenye, Xing, Yiqiao, Yang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225376/
https://www.ncbi.nlm.nih.gov/pubmed/35743555
http://dx.doi.org/10.3390/jcm11123485
_version_ 1784733603588997120
author He, Xuejun
Zhang, Ningzhi
Cao, Wenye
Xing, Yiqiao
Yang, Ning
author_facet He, Xuejun
Zhang, Ningzhi
Cao, Wenye
Xing, Yiqiao
Yang, Ning
author_sort He, Xuejun
collection PubMed
description Ocular diseases affect multiple eye parts and can be caused by pathogenic infections, complications of systemic diseases, genetics, environment, and old age. Understanding the etiology and pathogenesis of eye diseases and improving their diagnosis and treatment are critical for preventing any adverse consequences of these diseases. Recently, the advancement of high-throughput sequencing (HTS) technology has paved wide prospects for identifying the pathogenesis, signaling pathways, and biomarkers involved in eye diseases. Due to the advantages of HTS in nucleic acid sequence recognition, HTS has not only identified several normal ocular surface microorganisms but has also discovered many pathogenic bacteria, fungi, parasites, and viruses associated with eye diseases, including rare pathogens that were previously difficult to identify. At present, HTS can directly sequence RNA, which will promote research on the occurrence, development, and underlying mechanism of eye diseases. Although HTS has certain limitations, including low effectiveness, contamination, and high cost, it is still superior to traditional diagnostic methods for its efficient and comprehensive diagnosis of ocular diseases. This review summarizes the progress of the application of HTS in ocular diseases, intending to explore the pathogenesis of eye diseases and improve their diagnosis.
format Online
Article
Text
id pubmed-9225376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92253762022-06-24 Application Progress of High-Throughput Sequencing in Ocular Diseases He, Xuejun Zhang, Ningzhi Cao, Wenye Xing, Yiqiao Yang, Ning J Clin Med Review Ocular diseases affect multiple eye parts and can be caused by pathogenic infections, complications of systemic diseases, genetics, environment, and old age. Understanding the etiology and pathogenesis of eye diseases and improving their diagnosis and treatment are critical for preventing any adverse consequences of these diseases. Recently, the advancement of high-throughput sequencing (HTS) technology has paved wide prospects for identifying the pathogenesis, signaling pathways, and biomarkers involved in eye diseases. Due to the advantages of HTS in nucleic acid sequence recognition, HTS has not only identified several normal ocular surface microorganisms but has also discovered many pathogenic bacteria, fungi, parasites, and viruses associated with eye diseases, including rare pathogens that were previously difficult to identify. At present, HTS can directly sequence RNA, which will promote research on the occurrence, development, and underlying mechanism of eye diseases. Although HTS has certain limitations, including low effectiveness, contamination, and high cost, it is still superior to traditional diagnostic methods for its efficient and comprehensive diagnosis of ocular diseases. This review summarizes the progress of the application of HTS in ocular diseases, intending to explore the pathogenesis of eye diseases and improve their diagnosis. MDPI 2022-06-17 /pmc/articles/PMC9225376/ /pubmed/35743555 http://dx.doi.org/10.3390/jcm11123485 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
He, Xuejun
Zhang, Ningzhi
Cao, Wenye
Xing, Yiqiao
Yang, Ning
Application Progress of High-Throughput Sequencing in Ocular Diseases
title Application Progress of High-Throughput Sequencing in Ocular Diseases
title_full Application Progress of High-Throughput Sequencing in Ocular Diseases
title_fullStr Application Progress of High-Throughput Sequencing in Ocular Diseases
title_full_unstemmed Application Progress of High-Throughput Sequencing in Ocular Diseases
title_short Application Progress of High-Throughput Sequencing in Ocular Diseases
title_sort application progress of high-throughput sequencing in ocular diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225376/
https://www.ncbi.nlm.nih.gov/pubmed/35743555
http://dx.doi.org/10.3390/jcm11123485
work_keys_str_mv AT hexuejun applicationprogressofhighthroughputsequencinginoculardiseases
AT zhangningzhi applicationprogressofhighthroughputsequencinginoculardiseases
AT caowenye applicationprogressofhighthroughputsequencinginoculardiseases
AT xingyiqiao applicationprogressofhighthroughputsequencinginoculardiseases
AT yangning applicationprogressofhighthroughputsequencinginoculardiseases